Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
18 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Zhejiang Hisoar Pharmaceutical Co., Ltd. (Hisoar) is a manufacturer and distributor of fine chemicals and special raw drugs. The company offers raw drugs, which include antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs for both humans and animals. It produces fine chemicals such as medicine intermediates, active pharmaceutical ingredients and other customized and processed products.

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed

  
Source:
Document ID
GDPH139164D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Zhejiang Hisoar Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Zhejiang Hisoar Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Zhejiang Hisoar Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Zhejiang Hisoar Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Zhejiang Hisoar Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Zhejiang Hisoar Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deal Details106
  Partnerships101
    Visum Pharma Forms Joint Venture With Haixiang Pharma101
  Equity Offering111
    Zhejiang Hisoar Pharma Raises USD154.3 million in Private Placement of Shares111
    Hisoar Pharma Plans to Raise Upto USD328 Million in Private Placement of Shares121
    Zhejiang Hisoar Pharma Amends Private Placement Of Shares For US$76 Million131
  Debt Offering141
    Zhejiang Hisoar Completes Public Offering Of Bonds Due 2015 For US$47 Million141
  Acquisition151
    Zhejiang Hisoar Pharma To Acquire 70% Stake In Suzhou Pharma Company For US$19 Million151
Zhejiang Hisoar Pharmaceutical Co., Ltd. - Key Competitors161
Locations And Subsidiaries171
  Head Office171
Appendix181
  Methodology181
  About GlobalData181
  Contact Us181
  Disclaimer181

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zhejiang-Hisoar-Pharmaceutical-Co-Ltd-002099-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7855>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zhejiang-Hisoar-Pharmaceutical-Co-Ltd-002099-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7855>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research